🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06082284
Recruiting Observational

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

NCT06082284 · tracked via the Priya Life Science China tracker
Sponsor
Zhujiang Hospital
Phase
Observational
Started
2023-10-01
Last updated
2024-12-20

Condition(s) studied

Multiple MyelomaM Protein

Study summary

By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital; * Age: over 18 years old; * There are sufficient remaining serum samples and extensive informed consent has been signed. Exclusion Criteria: * Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases; * Improper storage or repeated freeze-thaw of remaining serum samples.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhujiang Hospital of Southern Medical University Guangzhou Guangdong Recruiting

More Zhujiang Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06082284 on ClinicalTrials.gov ↗ ← All trials in China